Allogeneic Anti-BCMA/GPRC5D Bispecific CAR-NK Cells (ACT-001) in Patients With Relapsed or Refractorymultiple Myeloma
Clinical trial NCT06594211 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06594211
- Sponsor
- RenJi Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-09
- Primary completion
- 2028-10-09
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.